Clene Inc. [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K	10-K	S-1
Revenues:
Supplements			0.2
Total revenues [+]	0.5	0.7	0.0	19.0
Royalties			0.0
Revenue growth	-34.6%	2310.0%	-99.8%
Cost of goods sold	0.0	0.3	0.0	0.0
Gross profit	0.4	0.4	0.0	19.0
Gross margin	94.5%	60.0%	100.0%	100.0%
Selling, general and administrative [+]	16.9	22.0	20.4	9.5
Sales and marketing				2.7
General and administrative	16.9	22.0		6.8
Other selling, general and administrative				2.7
Research and development	31.9	28.4		9.6
Other operating expenses			-18.8	16.3
EBITDA [+]	-47.4	-49.0		-15.5
EBITDA growth	-3.3%	3022.5%	-89.9%
EBITDA margin	-10019.0%	-6780.5%	-5233.3%	-81.3%
Depreciation and amortization	1.0	1.0		0.8
EBIT [+]	-48.4	-50.0	-1.6	-16.3
EBIT growth	-3.1%	3083.3%	-90.4%
EBIT margin	-10234.5%	-6912.6%	-5233.3%	-85.8%
Interest expense	3.3	0.9		0.1
Interest expense	3.3	0.9	1.0	0.1
Other income (expense), net [+]	21.8	40.7	-16.4	0.3
Gain (loss) on debt retirement	0.4
Unrealized gain/loss on derivatives	0.2	1.0	14.6
Other	0.3	0.0		0.0
Pre-tax income	-29.9	-10.2	-18.9	-16.2
Income taxes	0.0	-0.4	0.4	0.0
Tax rate	0.0%	4.2%		0.0%
Net income	-29.9	-9.7	-19.3	-16.2
Net margin	-6325.2%	-1347.2%	-64256.7%	-84.9%

Basic EPS [+]	($0.46)	($0.16)	($1.10)	($0.93)
Growth	190.0%	-85.6%	18.3%
Diluted EPS [+]	($0.46)	($0.16)	($1.10)	($0.93)
Growth	190.0%	-85.6%	18.3%

Shares outstanding (basic) [+]	65.2	61.6	17.5	17.4
Growth	5.9%	251.7%	0.8%
Shares outstanding (diluted) [+]	65.2	61.6	17.5	17.4
Growth	5.9%	251.7%	0.8%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.